BACKGROUND: Surgery is the best treatment for primary GIST and may be curative, but resection extension/completeness impact on the prognosis remains controversial. The authors aim was to evaluate the clinicopathological (CP) parameters and surgical margins status influence on GIST patients' outcome. MATERIALS AND METHODS: The study evaluated 113 consecutive patients with sporadic GIST; the influence of CP parameters on recurrence-free survival (RFS) and disease-specific survival (DSS) was determined by univariate analysis (UA) and multivariate analysis (MA). RESULTS: Of 104 cases, macroscopically complete resection was achieved in 96: R0 surgical margin status in 78 and R1 in 18. Recurrence rates (12.5%) were significantly lower in R0 (9.0%) than in R1 (27.8%). Tumor > 10 cm, mitotic count > 5/50 high power field (HPF), and high-risk GIST predicted poor RFS and DSS (UA). Disease-specific survival was significantly shorter after macroscopic incomplete (R2) resection, for mixed cellular morphology, and in tumors with necrosis (UA). High-risk GIST (p = 0.016) and R2 resection (p = 0.013) predicted poor DSS of patients (MA). CONCLUSIONS: High risk and positive macroscopic surgical margin status are parameters associated with poor disease-specific survival in GIST patients.
BACKGROUND: Surgery is the best treatment for primary GIST and may be curative, but resection extension/completeness impact on the prognosis remains controversial. The authors aim was to evaluate the clinicopathological (CP) parameters and surgical margins status influence on GIST patients' outcome. MATERIALS AND METHODS: The study evaluated 113 consecutive patients with sporadic GIST; the influence of CP parameters on recurrence-free survival (RFS) and disease-specific survival (DSS) was determined by univariate analysis (UA) and multivariate analysis (MA). RESULTS: Of 104 cases, macroscopically complete resection was achieved in 96: R0 surgical margin status in 78 and R1 in 18. Recurrence rates (12.5%) were significantly lower in R0 (9.0%) than in R1 (27.8%). Tumor > 10 cm, mitotic count > 5/50 high power field (HPF), and high-risk GIST predicted poor RFS and DSS (UA). Disease-specific survival was significantly shorter after macroscopic incomplete (R2) resection, for mixed cellular morphology, and in tumors with necrosis (UA). High-risk GIST (p = 0.016) and R2 resection (p = 0.013) predicted poor DSS of patients (MA). CONCLUSIONS: High risk and positive macroscopic surgical margin status are parameters associated with poor disease-specific survival in GIST patients.
Authors: J A Crosby; C N Catton; A Davis; J Couture; B O'Sullivan; R Kandel; C J Swallow Journal: Ann Surg Oncol Date: 2001 Jan-Feb Impact factor: 5.344
Authors: A M Gouveia; A P Pimenta; J M Lopes; A F Capelinha; S S Ferreira; C Valbuena; M C Oliveira Journal: Dis Esophagus Date: 2005 Impact factor: 3.429
Authors: Hui Yan; Pierre Marchettini; Yair I Z Acherman; Sue Ann Gething; Erwin Brun; Paul H Sugarbaker Journal: Am J Clin Oncol Date: 2003-06 Impact factor: 2.339
Authors: Peter C Wu; Alex Langerman; Christopher W Ryan; John Hart; Susan Swiger; Mitchell C Posner Journal: Surgery Date: 2003-10 Impact factor: 3.982
Authors: Martin D McCarter; Cristina R Antonescu; Karla V Ballman; Robert G Maki; Peter W T Pisters; George D Demetri; Charles D Blanke; Margaret von Mehren; Murray F Brennan; Linda McCall; David M Ota; Ronald P DeMatteo Journal: J Am Coll Surg Date: 2012-07 Impact factor: 6.113
Authors: Jeffrey S Mino; Alfredo D Guerron; Rosebel Monteiro; Kevin El-Hayek; Jeffrey L Ponsky; Deepa T Patil; R Matthew Walsh Journal: Surg Endosc Date: 2015-08-15 Impact factor: 4.584
Authors: Ferdinando C M Cananzi; Bruno Lorenzi; Ajay Belgaumkar; Charlotte Benson; Ian Judson; Satvinder Mudan Journal: Langenbecks Arch Surg Date: 2014-01-12 Impact factor: 3.445
Authors: Olga Martinho; António Gouveia; Paula Silva; Amadeu Pimenta; Rui Manuel Reis; José Manuel Lopes Journal: Virchows Arch Date: 2009-08-25 Impact factor: 4.064
Authors: Michelle L Bryan; Nora C Fitzgerald; Edward A Levine; Perry Shen; John H Stewart; Konstantinos I Votanopoulos Journal: Am Surg Date: 2014-09 Impact factor: 0.688
Authors: Brent A Willobee; Hallie J Quiroz; Matthew S Sussman; Chad M Thorson; Juan E Sola; Eduardo A Perez Journal: Transl Gastroenterol Hepatol Date: 2018-08-08